# Mind Pharmaceuticals Corp — Form D

Mind Pharmaceuticals Corp of NEW HAVEN, CT, a company, filed a Form D exempt-offering notice with the SEC on 2025-05-15. The offering totals $8.0M, of which $50K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2025-05-15
- Form: D
- Accession: 0002068220-25-000001
- Industry: Biotechnology
- Exemptions: 04
- Total offering: $8.0M
- Amount sold: $50K
- Remaining: $8.0M
- Minimum investment: $10K
- Investors: 1
- Date of first sale: 2025-05-01
- Security types: equity, debt
- Revenue range: No Revenues
- SEC file number: 021-546235

## Issuer

- Name: Mind Pharmaceuticals Corp
- CIK: 0002068220
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 12-R, 100 YORK STREET, NEW HAVEN, CT, 06511
- Phone: 908-331-2511

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Prakash Krishna Mandgi | Director | Jersey City, NJ |
| Krishna Ravindranathan | Director | New Haven, CT |
| Prakash Krishna Mandgi | Executive Officer | Jersey City, NJ |
| Krishna Ravindranathan | Executive Officer | New Haven, CT |

## More

- [CIK 2068220 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2068220&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002068220-25-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.